Orphan Pharma Consulting
We are Medical Affairs specialists
with a wealth of knowledge and experience in orphan diseases
to support our clients in bringing life-changing medicines to their patients
Dr. Zlatko Sisic
Founder and Managing Director
About Us
Zlatko Sisic is a medical leader with over 20 years of experience in pharma and biotech, working across sales, marketing, market access and medical affairs with a particular focus on orphan diseases.
Zlatko specialises in developing product and disease medical strategies, data generation, and building medical affairs functions and teams. Prior to setting up Orphan Pharma Consulting in December 2022, Zlatko most recently held the position of Vice President, Head of Medical Affairs Europe at BioCryst Pharmaceuticals. He also has a leadership track record established in Eisai, ViroPharma and BioMarin.
Zlatko holds a medical degree from the University of Belgrade, an MBA from the Oxford Brooks Business School, and a post-graduate Diploma in Pharmaceutical Medicine from King’s College University.
Our Mission
Our Mission is to “Empower pioneers in drug development to unlock the potential for sustained commercial growth and provide patients with orphan diseases and their families the opportunity to live their lives to the full.”
Why Are We Here?
We passionately believe that as innovation transforms the landscape of orphan diseases, Medical Affairs needs to evolve from being primarily a support function to becoming one of the core pillars within the organisation.
We enable organisations to engage in this transformative process to realise their commercial opportunities and meet obligations to the communities they serve.
What We Do?
Our core focus is to bring medicines to patients with orphan diseases by reaching two ultimate goals:
Stakeholder Advocacy and Product Reimbursement
How We Do It?
We work with you to develop the Medical Affairs function to be the owner of scientific knowledge and driver of scientific strategy by leading activities such as:
Tailored scientific engagement
Evidence generation to accelerate access to treatment and maximise patient experiences and outcomes
We work to deliver disease and product scientific strategy and evidence-generation activities by:
Engaging with key stakeholders such as clinical experts, patient advocates and payers
Understanding evidence needs in individual markets
Advising on the design of clinical trials and strategies for closing data gaps
Creating a product value proposition designed to meet the criteria for successful evidence based medicine and pharmacoeconomic evaluations
